Roche’s new timesaving formulation of Herceptin approved in Europe for the treatment of HER2-positive breast cancer By Araceli Richardson|2020-08-18T00:58:00-07:00September 2, 2013|
Halozyme Announces Positive Opinion from CHMP On Roche’s Herceptin SC for European Approval By Araceli Richardson|2020-08-18T00:58:00-07:00June 28, 2013|
Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union By Araceli Richardson|2020-08-18T00:58:00-07:00March 22, 2013|
‘Small Ball’ Investing as an Alternative Model in Life Sciences By Jonathan Lim, M.D.|2020-07-28T18:19:03-07:00January 9, 2013|
